Range Nuclear Renaissance ETF vs Revolution Medicines Inc. Common Stock — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Revolution Medicines Inc. Common Stock trades at $189.4 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 57.7× Range Nuclear Renaissance ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 18 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NUKZ | RVMD | |
|---|---|---|
Market Cap | $698.21M | $40.32B |
Volume | 57,444 | 4,855,734 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $221.15 |
52-Week Low | $60.23 | $47.50 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | — | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →